These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9543235)

  • 1. WAY 100,635 enhances both the 'antidepressant' actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortex.
    Millan MJ; Brocco M; Veiga S; Cistarelli L; Melon C; Gobert A
    Eur J Pharmacol; 1998 Jan; 341(2-3):165-7. PubMed ID: 9543235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.
    Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
    Neuroscience; 1999; 93(4):1251-62. PubMed ID: 10501449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935.
    Gobert A; Rivet JM; Cistarelli L; Millan MJ
    J Neurochem; 1997 Mar; 68(3):1159-63. PubMed ID: 9048762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release.
    Gobert A; Rivet JM; Audinot V; Newman-Tancredi A; Cistarelli L; Millan MJ
    Neuroscience; 1998 May; 84(2):413-29. PubMed ID: 9539213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats.
    Gobert A; Rivet JM; Cistarelli L; Melon C; Millan MJ
    J Neurochem; 1997 Dec; 69(6):2616-9. PubMed ID: 9375697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buspirone enhances duloxetine- and fluoxetine-induced increases in dialysate levels of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely moving rats.
    Gobert A; Rivet JM; Cistarelli JM; Millan MJ
    J Neurochem; 1997 Mar; 68(3):1326-9. PubMed ID: 9048781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-methyl-d-aspartate receptors regulate 5-HT release in the raphe nuclei and frontal cortex of freely moving rats: differential role of 5-HT1A autoreceptors.
    Pallotta M; Segieth J; Whitton PS
    Brain Res; 1998 Feb; 783(2):173-8. PubMed ID: 9507110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potent activity of the 5-HT1A receptor agonists, S 14506 and S 14671, in the rat forced swim test is blocked by novel 5-HT1A receptor antagonists.
    Schreiber R; Brocco M; Gobert A; Veiga S; Millan MJ
    Eur J Pharmacol; 1994 Dec; 271(2-3):537-41. PubMed ID: 7705455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of co-administration of a monoamine oxidase inhibitor and a 5-HT1A receptor antagonist on 5-hydroxytryptamine cell firing and release.
    Sharp T; Gartside SE; Umbers V
    Eur J Pharmacol; 1997 Feb; 320(1):15-9. PubMed ID: 9049597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical role for D1 receptors in the 5-HT1A-mediated facilitation of in vivo acetylcholine release in rat frontal cortex.
    Consolo S; Ramponi S; Ladinsky H; Baldi G
    Brain Res; 1996 Jan; 707(2):320-3. PubMed ID: 8919313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential role of 5-HT1A and 5-HT1B receptors on the antinociceptive and antidepressant effect of tramadol in mice.
    Berrocoso E; Rojas-Corrales MO; Mico JA
    Psychopharmacology (Berl); 2006 Sep; 188(1):111-8. PubMed ID: 16832657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acute treatment with YM992 on extracellular serotonin levels in the rat frontal cortex.
    Hatanaka K; Yatsugi S; Yamaguchi T
    Eur J Pharmacol; 2000 Apr; 395(1):23-9. PubMed ID: 10781669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.
    Jordan S; Chen R; Koprivica V; Hamilton R; Whitehead RE; Tottori K; Kikuchi T
    Eur J Pharmacol; 2005 Jul; 517(3):165-73. PubMed ID: 15985260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.
    Koek W; Vacher B; Cosi C; Assié MB; Patoiseau JF; Pauwels PJ; Colpaert FC
    Eur J Pharmacol; 2001 May; 420(2-3):103-12. PubMed ID: 11408031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of duloxetine and WAY100635 on pudendal inhibition of bladder overactivity in cats.
    Reese J; Xiao Z; Schwen Z; Matsuta Y; Shen B; Wang J; Roppolo JR; de Groat WC; Tai C
    J Pharmacol Exp Ther; 2014 Jun; 349(3):402-7. PubMed ID: 24667547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D(1) and D(2) receptor agonism enhances antinociception mediated by the serotonin and noradrenaline reuptake inhibitor duloxetine in the rat formalin test.
    Munro G
    Eur J Pharmacol; 2007 Dec; 575(1-3):66-74. PubMed ID: 17725928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of bladder overactivity by duloxetine in combination with foot stimulation or WAY-100635 treatment in cats.
    Schwen Z; Matsuta Y; Shen B; Wang J; Roppolo JR; de Groat WC; Tai C
    Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1663-8. PubMed ID: 24154699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats.
    Leiser SC; Pehrson AL; Robichaud PJ; Sanchez C
    Br J Pharmacol; 2014 Sep; 171(18):4255-72. PubMed ID: 24846338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combined treatment with aripiprazole and antidepressants on the MK-801-induced deficits in recognition memory in novel recognition test and on the release of monoamines in the rat frontal cortex.
    Hereta M; Kamińska K; Białoń M; Wąsik A; Lorenc-Koci E; Rogóż Z
    Behav Brain Res; 2020 Sep; 393():112769. PubMed ID: 32535184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.